Stocks and Investing
Stocks and Investing
Mon, May 17, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 14, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kalpit Patel Initiated (ALLO) at Strong Buy and Held Target at $52 on, May 14th, 2021
Kalpit Patel of B. Riley Securities, Initiated "Allogene Therapeutics, Inc." (ALLO) at Strong Buy and Held Target at $52 on, May 14th, 2021.
Kalpit has made no other calls on ALLO in the last 4 months.
There are 2 other peers that have a rating on ALLO. Out of the 2 peers that are also analyzing ALLO, 0 agree with Kalpit's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kalpit
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $43 on, Monday, March 1st, 2021
- Benjamin Burnett of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $43 on, Tuesday, January 26th, 2021
Contributing Sources